Historical record - last NADAC effective date: 2/22/2023
Product Information
DEXTROAMPHETAMINE ER 15 MG CAP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $1.3827 per EA under NDC 00115992910. Its NADAC has been published 211 times since Feb 13, 2019.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115992910
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
2/22/2023
Active Ingredients
DEXTROAMPHETAMINE SULFATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA017078FDA Approved
Before 1982
TE Code
AB
On Market Since
8/2/1976
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMPHETAMINE ER 15 MG CAP has been published 211 times since Feb 13, 2019, and over the history we have for it it has declined 17.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3827 per EA |
|---|---|
| All-time high | $2.3813 (Aug 14, 2019) |
| All-time low | $1.2271 (Nov 23, 2022) |
| Median price | $1.7337 |
| Average price | $1.7194 |
| Largest weekly change | +35.4% (Jan 18, 2023) |
| Weeks tracked | 211 |
| Tracking since | Feb 13, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-18.1%
All
-17.5%
Last surveyed Feb 22, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextroamphetamine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXTROAMPHETAMINE ER 15 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMPHETAMINE ER 15 MG CAP, manufactured by Amneal Pharmaceuticals of New York LLC, is $1.3827 per EA (NDC 00115992910), effective Feb 22, 2023.
How has the price of DEXTROAMPHETAMINE ER 15 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMPHETAMINE ER 15 MG CAP has declined 17.5%. It has been tracked across 211 weekly CMS publications since Feb 13, 2019.
What are the highest and lowest recorded NADAC prices for DEXTROAMPHETAMINE ER 15 MG CAP?
Since Feb 13, 2019, the NADAC for DEXTROAMPHETAMINE ER 15 MG CAP has ranged from a low of $1.2271 (Nov 23, 2022) to a high of $2.3813 (Aug 14, 2019), with a median of $1.7337 per EA.
Are there cheaper alternatives to DEXTROAMPHETAMINE ER 15 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMPHETAMINE ER 15 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMPHETAMINE ER 15 MG CAP?
DEXTROAMPHETAMINE ER 15 MG CAP (NDC 00115992910) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.